Valerie S. LeBleu
0000-0002-8514-8551
Publication & Citation Trends
Publications
0 total
Engineered immunomodulatory extracellular vesicles from epithelial cells with capacity for stimulation of innate and adaptive immunity in cancer and autoimmunity
Cited by 9
Semantic Scholar
Abstract CT265: KRASG12Dtargeting using engineered exosomes in pancreatic cancer: Results from the iEXPLORE phase 1 trial
Cited by 1
Semantic Scholar
KRASG12D-Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients OA
Cited by 17
Semantic Scholar
Abstract B082: Extinction of oncogenic Kras in genetic mouse models eradicates pancreatic cancer by inducing Fas-dependent apoptosis by CD8+ T cells OA
Cited by 0
Semantic Scholar
Vascular heterogeneity of tight junction Claudins guides organotropic metastasis OA
Cited by 11
Semantic Scholar
Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity OA
Cited by 24
Semantic Scholar
Abstract C084: iExplore: A phase I study of mesenchymal stem cell derived exosomes with KrasG12D siRNA for metastatic pancreas cancer patients harboring the KrasG12D mutation
Cited by 6
Semantic Scholar
Genetic reprogramming with stem cells regenerates glomerular epithelial podocytes in Alport syndrome OA
Cited by 2
Semantic Scholar
Research Topics
Pancreatic and Hepatic Oncology Research
(28)
Cancer Cells and Metastasis
(23)
Extracellular vesicles in disease
(23)
Cancer Immunotherapy and Biomarkers
(15)
TGF-β signaling in diseases
(13)
Affiliations
Florida Institute of Technology
Northwestern University
U.S. National Science Foundation
Beth Israel Deaconess Medical Center
The University of Texas MD Anderson Cancer Center
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.